We use some essential cookies to make this website work.
We鈥檇 like to set additional cookies to understand how you use 188体育, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the groups that should be prioritised for vaccination.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.
Statements from the Joint Committee on Vaccination and Immunisation (JCVI) about use of Bexsero庐 meningococcal B vaccine in the UK.
Interim advice from the JCVI on the requirements for a potential COVID-19 booster vaccination programme for winter 2021 to 2022
For 2022, the primary aim of the COVID-19 vaccination programme continues to be the prevention of severe disease (hospitalisation and mortality) arising from COVID-19.
The Joint Committee on Vaccination and Immunisation (JCVI) statement on vaccine dose prioritisation in response to the monkeypox outbreak.
Don鈥檛 include personal or financial information like your National Insurance number or credit card details.
To help us improve 188体育, we鈥檇 like to know more about your visit today. .